NCT04192656

The Effect of PAP on ISSHL Comorbided With OSA

The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 102 (estimated)
• Sponsor: Beijing Tsinghua Chang Gung Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Conditions

• Sudden Hearing Loss
• Obstructive Sleep Apnea

Interventions

Type	Name	Description
DEVICE	non-invasive positive airway pressure	non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea
DRUG	Methylprednisolone Hemisuccinate	Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss
DRUG	Ginaton	ginnaton is ginkgo biloba extract

Timeline

• Start date: 2019-11-01
• Primary completion: 2024-12-01
• Completion: 2029-12-01
• First posted: 2019-12-10
• Last updated: 2019-12-10

Locations

1 site across 1 country: China